News summary

Fight Aging! Newsletter, October 5th 2026

Source: Fight Aging! • Published: 04 Oct 2026, 11:51

Summarized by Masters of Longevity from Fight Aging!.

Geroscience-focused newsletter highlighting recent research on brain‑intrinsic immune signaling and nuanced reviews of mTOR as a complex aging regulator.

Fight Aging! Newsletter, October 5th 2026
Key Takeaways
  • Direct intracortical blockade of PD-L1 in an Alzheimer’s mouse model restored microglial process motility and neuronal calcium activity within seven days.
  • Targeting brain-intrinsic glial PD-1/PD-L1 signaling reduced amyloid-β plaque burden and increased plaque-associated microglia in treated mice.
  • MTOR functions as a context-dependent signaling hub through mTORC1 and mTORC2, so nuanced modulation rather than single-target inhibition may better support healthy aging.
Read the full article at Fight Aging! ↗

Continue exploring

Recommended MoL Picks

MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickFrom Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.